This is probably the most important publication we have published for trainees and senior oncologists alike. This provides answers to almost every question you have about surrogate endpoints in oncology. This is a must-read for anyone with an interest in cancer trials. FREE!
Our brilliant @ChelwestFT ADOC team were delighted to be recognised by the @RMPartnersNHS rapid diagnostic clinic celebration day. The first clinic of its kind to be developed for investigating patients with vague symptoms to diagnose cancer. Earlier diagnosis improves outcomes!
@DrLesleyDawson2@marklewismd@JCO_ASCO I’m doing a teaching session on adjuvant chemo for colon cancer for our resident doctors - “Trolley problem” is a great analogy!
We have 2 trials of bispecific antibodies in lung cancer open and running @ChelwestFT
In fact, recruited the first patients in Europe to both of these
🦸
Great to share our data & generate discussion around management of malignant bowel obstruction @myESMO . Data collected from the @WestMidHospital@ChelwestFT AOS team highlighting need for MDT involvement and national guidelines to improve patient care and experience #ESMO2024
Malignant bowel obstruction: from outstanding @WestMidHospital AOS team
❗️24% died during admission
❗️74% had no further SACT
❗️Only 50% referred to palliative care
👉 Need MDT discussion for every case
👉 Need national guidelines for best management
#ESMO2024
@Leeshcons@samwarb@peterc1982mfc@oasis I haven’t received my confirmation but to be fair I only did it 20 mins ago and I guess a lot of people will be doing it this morning! Here we go again…
Great to join @Cancer52org at the #bigcancer52conversation today, talking about the DETERMINE clinical trial which is open for patients of all ages with rare cancer across the ECMC network @CR_UK@ECMC_UK
Joe's story https://t.co/BtNLJUjdgb After emergency surgery and 18 cycles of chemotherapy, Joe is running to raise money for @MulberryCentre on his chemo break. What an incredible person living with bowel cancer and such a worthy cause to support. Please consider donating!
Nice to see some of our @ChelwestFT ADOC data being shared at #BTOG24. Our RDC has a brilliant team of GPs, nurses and consultants to improve faster diagnosis of cancer in patients with complex and vague symptoms
Proud to see @ChelwestFT Rapid Diagnostic Clinic data presented at #BTOG24
👉 Lung is commonest cancer diagnosed
👉 RDC presentation associated with older age, complex symptoms & raised inflammatory markers
👉 RDCs import patent in presentation of lung cancer
#LCSM#BTOG24
A smokefree future could mean tens of thousands fewer cancer deaths each year in the UK.
Read more about why today's tobacco Age of Sale legislation is important, including thoughts from our Executive Director @IanWalker_CRUK 👇 https://t.co/BXTdd7ts1U
#SmokefreeUK
Delighted to head to Westminster today to support @Cancer52org manifesto for rare cancers. We are passionate about supporting patients with rare cancers and improving outcomes. We hope many of them will be involved with the DETERMINE trial running across the UK @ECMC_UK@CR_UK